A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranivir and Ritonavir use in HIV-1 Infected Subjects

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/033/31/09

Funding

  • Boehringer-Ingelheim: $8,171.00